Background And Analysis Of The Taxation Of Multinational Enterprises And The Potential Reallocation Of Taxing Rights Under the OECD’s Pillar One
View DetailsMacroeconomic Analysis Of H.R. 7024, The "Tax Relief For American Families And Workers Act of 2024," As Ordered Reported By The Committee on Ways And Means, On January 19, 2024
View DetailsEstimated Revenue Effects Of The Chairman's Amendment In The Nature Of A Substitute To H.R. 7024, The "Tax Relief For American Families And Workers Act of 2024," Scheduled For Markup By The Committee On Ways And Means on January 19, 2024
View DetailsDescription Of The Chairman's Amendment In The Nature Of A Substitute To H.R. 7024, The "Tax Relief For American Families And Workers Act of 2024"
View DetailsEstimated Revenue Effects Of H.R. 7024, The "Tax Relief For American Families and Workers Act of 2024," Scheduled For Markup By The Committee on Ways And Means On January 19, 2024
View DetailsDescription Of H.R. 7024, The "Tax Relief For American Families and Workers Act of 2024"
View DetailsGeneral Explanation Of Tax Legislation Enacted In The 117th Congress (Hard copies unavailable)
View DetailsEstimates Of Federal Tax Expenditures For Fiscal Years 2023-2027
View DetailsBackground On Cash-Flow And Consumption-Based Approaches To Taxation
View DetailsDescription Of The Chairman’s Amendment In The Nature Of A Substitute To H.R. 5988
View DetailsDescription Of H.R. 5988, The “United States-Taiwan Expedited Double-Tax Relief Act"
View DetailsDescription Of The Chairman’s Modification To The Chairman’s Mark Of The “United States-Taiwan Expedited Double-Tax Relief Act"
View DetailsDescription Of The Chairman’s Mark Of The “United States-Taiwan Expedited Double-Tax Relief Act"
View DetailsBackground And Analysis Of The Taxation Of Income Earned By Multinational Enterprises
View DetailsDescription Of The Chairman’s Amendment In The Nature Of A Substitute To H.R. 3938, The “Build It In America Act"
View DetailsEstimated Revenue Effects Of H.R. 3938, The “Build It In America Act" Scheduled For Markup By The Committee On Ways And Means On June 13, 2023
View DetailsPresent Law And Economic Background Relating To Pharmaceutical Manufacturers And U.S. International Tax Policy
View Details